SYNEXUS Trademark

Trademark Overview

On Friday, July 22, 2022, a trademark application was filed for SYNEXUS with the United States Patent and Trademark Office. The USPTO has given the SYNEXUS trademark a serial number of 97516473. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2024. This trademark is owned by Synexus Clinical Research US, Inc.. The SYNEXUS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Recruitment and selection services relating to clinical trials, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; business management services in the field of clinical trials, namely, providing information management services; providing marketing services for the medical and pharmaceutical products of others; Collection and compilation of market research information for clinical trials; business information, advisory and consultancy services relating to clinical trials
synexus

General Information

Serial Number97516473
Word MarkSYNEXUS
Filing DateFriday, July 22, 2022
Status700 - REGISTERED
Status DateTuesday, October 1, 2024
Registration Number7524149
Registration DateTuesday, October 1, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements

Goods and ServicesRecruitment and selection services relating to clinical trials, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; business management services in the field of clinical trials, namely, providing information management services; providing marketing services for the medical and pharmaceutical products of others; Collection and compilation of market research information for clinical trials; business information, advisory and consultancy services relating to clinical trials

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, August 15, 2022
Primary Code035
First Use Anywhere DateSaturday, December 31, 2016
First Use In Commerce DateSaturday, December 31, 2016

Trademark Owner History

Party NameSynexus Clinical Research US, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWilmington, NC 28401
Party NameSynexus Clinical Research US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, NC 28401
Party NameSynexus Clinical Research US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, NC 28401

Trademark Events

Event DateEvent Description
Wednesday, July 27, 2022NEW APPLICATION ENTERED
Monday, August 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 9, 2023ASSIGNED TO EXAMINER
Thursday, May 11, 2023NON-FINAL ACTION WRITTEN
Thursday, May 11, 2023NON-FINAL ACTION E-MAILED
Thursday, May 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 11, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, August 11, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, August 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 8, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, September 8, 2023EXAMINERS AMENDMENT E-MAILED
Friday, September 8, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 8, 2023EXAMINER'S AMENDMENT ENTERED
Friday, September 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 12, 2024USE AMENDMENT FILED
Wednesday, June 12, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 12, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, June 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2024SOU EXTENSION 1 FILED
Wednesday, June 12, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 31, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 1, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 29, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 29, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 1, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 1, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

synexus clinical trials services information business management namely providing relating pharmaceutical